![EMJ Neurology 8 [Supplement 2] 2020 Feature Image](https://emj.emg-health.com/wp-content/uploads/sites/2/2020/12/EMJ-Neurology-8-Supplement-2-2020-Feature-Image-940x563.jpg)
![EMJ Neurology 8 [Supplement 1] 2020 Feature Image](https://emj.emg-health.com/wp-content/uploads/sites/2/2020/10/EMJ-Neurology-8-Supplement-1-2020-Feature-Image-940x563.jpg)
The table shows major sphingosine 1-phosphate receptor modulator clinical trials in multiple sclerosis. Read on to… twitter.com/i/web/status/1…
Posted 24 January
Discover our #Neurology Editorial Board on our website along with articles and interviews! ow.ly/fx5h30pK8Ms https://t.co/WMUj2Oyq5X
Posted 23 January
Pontocerebellar hypoplasia is a group of rare diseases related to brain development. This paper provides a detailed… twitter.com/i/web/status/1…
Posted 22 January
In this supplement to EMJ Neurology, two leading experts in multiple sclerosis (MS), explored the sphingosine 1-pho… twitter.com/i/web/status/1…
Posted 21 January
Resistance to Eye Opening in Patients with Disorders of Consciousness: bit.ly/2S9j7ul
#Neurology… twitter.com/i/web/status/1…
Posted 20 January
